Press launch MHRA approves GLP –one receptor agonist semaglutide to reduce threat of significant coronary heart complications in obese or overweight Grown ups Semaglutide is the first fat reduction drug approved in britain as being a preventative treatment for the people with proven heart problemsenhanced coronary heart fee. Wegovy® can increase